WARDWIZARD [WARDHEALTH] vs Authum Investment [AIIL] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: WARDWIZARD HEALTHCARE LIMITED wins in 5 metrics, Authum Investment & Infrastructure Ltd. wins in 13 metrics, with 0 ties. Authum Investment & Infrastructure Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric WARDWIZARD HEALTHCARE LIMITED Authum Investment & Infrastructure Ltd. Better
P/E Ratio (TTM) -0.41 11.72 Authum Investment & Infrastructure Ltd.
Price-to-Book Ratio -0.31 2.62 Authum Investment & Infrastructure Ltd.
Debt-to-Equity Ratio -0.85 20.29 Authum Investment & Infrastructure Ltd.
PEG Ratio 0.01 -0.17 WARDWIZARD HEALTHCARE LIMITED
EV/EBITDA -2.32 9.56 Authum Investment & Infrastructure Ltd.
Profit Margin (TTM) -191.01% 110.11% Authum Investment & Infrastructure Ltd.
Operating Margin (TTM) -104.61% 78.85% Authum Investment & Infrastructure Ltd.
EBITDA Margin (TTM) N/A 78.85% N/A
Return on Equity 87.16% 28.87% WARDWIZARD HEALTHCARE LIMITED
Return on Assets (TTM) -31.04% 26.36% Authum Investment & Infrastructure Ltd.
Free Cash Flow (TTM) $-16.42M $2.53B Authum Investment & Infrastructure Ltd.
Dividend Yield N/A 0.06% N/A
1-Year Return 107.32% -7.28% WARDWIZARD HEALTHCARE LIMITED
Price-to-Sales Ratio (TTM) 1.20 12.91 WARDWIZARD HEALTHCARE LIMITED
Enterprise Value $41.15M $433.60B Authum Investment & Infrastructure Ltd.
EV/Revenue Ratio 4.46 13.14 WARDWIZARD HEALTHCARE LIMITED
Gross Profit Margin (TTM) -66.28% 77.18% Authum Investment & Infrastructure Ltd.
Revenue per Share (TTM) $38 $39 Authum Investment & Infrastructure Ltd.
Earnings per Share (Diluted) $-71.88 $42.81 Authum Investment & Infrastructure Ltd.
Beta (Stock Volatility) 0.46 -0.84 Authum Investment & Infrastructure Ltd.

WARDWIZARD HEALTHCARE LIMITED vs Authum Investment & Infrastructure Ltd. Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
WARDWIZARD HEALTHCARE LIMITED0.00%0.00%0.00%0.00%4.98%0.00%
Authum Investment & Infrastructure Ltd.15.26%14.58%10.83%17.96%1.53%-15.47%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
WARDWIZARD HEALTHCARE LIMITED107.32%151.89%151.89%151.89%151.89%151.89%
Authum Investment & Infrastructure Ltd.-7.28%170.87%170.87%170.87%170.87%170.87%

Performance & Financial Health Analysis: WARDWIZARD HEALTHCARE LIMITED vs Authum Investment & Infrastructure Ltd.

MetricWARDHEALTHAIIL
Market Information
Market Cap i₹11.11M₹426.10B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i50353,228
90 Day Avg. Volume i171,056,091
Last Close₹45.34₹530.15
52 Week Range₹21.87 - ₹45.34₹400.00 - ₹683.00
% from 52W High0.00%-22.38%
All-Time High₹45.34 (Dec 22, 2025)₹3,305.00 (Oct 10, 2025)
% from All-Time High0.00%-83.96%
Growth Metrics
Quarterly Revenue Growth0.97%-0.42%
Quarterly Earnings Growth-0.11%-0.70%
Financial Health
Profit Margin (TTM) i-1.91%1.10%
Operating Margin (TTM) i-1.05%0.79%
Return on Equity (TTM) i0.87%0.29%
Debt to Equity (MRQ) i-0.8520.29
Cash & Liquidity
Book Value per Share (MRQ)₹-145.25₹191.73
Cash per Share (MRQ)₹0.55₹12.13
Operating Cash Flow (TTM) i₹-32,040,000₹70.10B
Levered Free Cash Flow (TTM) i₹-27,133,000₹42.41B
Dividends
Last 12-Month Dividend Yield iN/A0.06%
Last 12-Month Dividend iN/A₹1.50

Valuation & Enterprise Metrics Analysis: WARDWIZARD HEALTHCARE LIMITED vs Authum Investment & Infrastructure Ltd.

MetricWARDHEALTH (Apr 24, 2026)AIIL (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-0.4111.72
Forward P/E iN/AN/A
PEG Ratio i0.01-0.17
Price to Sales (TTM) i1.2012.91
Price to Book (MRQ) i-0.312.62
Market Capitalization
Market Capitalization i₹11.11M₹426.10B
Enterprise Value i₹41.15M₹433.60B
Enterprise Value Metrics
Enterprise to Revenue i4.4613.14
Enterprise to EBITDA i-2.329.56
Risk & Other Metrics
Beta i0.46-0.84
Book Value per Share (MRQ) i₹-145.25₹191.73

Financial Statements Comparison: WARDWIZARD HEALTHCARE LIMITED vs Authum Investment & Infrastructure Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricWARDHEALTH (2025)AIIL (2025)
Revenue/Sales i4.17M28.45B
Cost of Goods Sold i7.09M628.30M
COGS % of Revenue i170.1%2.2%
Gross Profit i-2.92M27.82B
Gross Margin i-70.1%97.8%
Research & Development iN/AN/A
Operating Income (EBIT) i-22.74M41.45B
Operating Margin i-545.3%145.7%
EBITDA i-17.79M45.34B
EBITDA Margin i-426.5%159.4%
Pre-Tax Income i-28.25M40.67B
Pre-Tax Income % of Revenue i-677.4%143.0%
Income Tax i-1.12M-1.74B
Income Tax % of Revenue i-26.8%-6.1%
Net Income (Profit) i-27.13M42.41B
Profit Margin i-650.6%149.1%

Balance Sheet & Liquidity Metrics

MetricWARDHEALTH (2025)AIIL (2025)
Cash & Equivalents i275,0001.08B
Total Current Assets i3.50M32.75B
Total Current Assets % of Revenue i83.8%115.1%
Total Current Liabilities i48.32M10.38B
Total Current Liabilities % of Revenue i1,158.7%36.5%
Long-Term Debt i69.75M3.60B
Long-Term Debt % of Revenue i1,672.8%12.7%
Total Shareholders Equity i-31.13M146.89B
Retained Earnings i-33.58M28.29B
Retained Earnings % of Revenue i-805.3%99.4%
Property, Plant & Equipment i72.78M21.90M

Cash Flow Statement Comparison

MetricWARDHEALTH (2025)AIIL (2025)
Operating Cash Flow i-32.04M70.10B
Operating Cash Flow % of Revenue i-768.3%246.4%
Capital Expenditures i-79,000-680.70M
Free Cash Flow i-16.42M2.53B
FCF Margin i-393.9%8.9%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricWARDHEALTHAIIL
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i245,000849.23M
Float Shares i14,306165.22M
% Held by Insiders i94.16%83.07%
% Held by Institutions i0.00%7.04%
% Held by Public i5.84%9.89%

Dividend Analysis & Yield Comparison: WARDWIZARD HEALTHCARE LIMITED vs Authum Investment & Infrastructure Ltd.

MetricWARDHEALTHAIIL
Last 12-Month Dividend iN/A₹1.50
Last 12-Month Dividend Yield iN/A0.06%
3-Year Avg Annual Dividend iN/A₹0.50
3-Year Avg Dividend Yield iN/A0.04%
3-Year Total Dividends iN/A₹1.50
Ex-Dividend DateN/AMay 16, 2025